Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Cancer|April 1, 1982
Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphomaW E Evans, A Tsiatis, G Rivera, et al.The Journal of Pediatrics|October 1, 1994
Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemiaW R Crom, S S de Graaf, T Synold, et al.Cancer|September 1, 1988
Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusionM V Relling, F B Stapleton, J Ochs, et al.Investigational New Drugs|January 1, 1996
Topoisomerase I interactive drugs in children with cancerC F Stewart, W C Zamboni, W R Crom, et al.The Journal of Infectious Diseases|November 24, 1999
Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infantsJ H Rodman, P M Flynn, B Robbins, et al.Pharmacotherapy|January 1, 1992
Variability in teniposide plasma protein binding is correlated with serum albumin concentrationsW P Petros, J H Rodman, M V Relling, et al.Cancer|February 15, 1991
Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemiaS J Kellie, W M Crist, C H Pui, et al.Journal of Pediatric Hematology/Oncology|August 14, 1998
High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms tumorR Dagher, S Kreissman, K A Robertson, et al.Archives of Internal Medicine|April 1, 1984
Clinical studies with computer-assisted initial lidocaine therapyJ H Rodman, R W Jelliffe, E Kolb, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemiaW E Evans, J H Rodman, M V Relling, et al.Pageof 11